Protiva Biotherapeutics INC

Protiva is a development stage biotechnology company, focused on pharmaceutical products to fight serious human disease. Protiva's proprietary SNALP technology enables the development of novel nucleic acid-based drugs, such as those that utilize siRNA. Protiva was founded in September of 2000 based on technology developed at The University of British Columbia.Protiva's headquarters is in Seattle, WA and its R&D facility is in Vancouver, B.C. Protiva's incorporation in Delaware is pending

Contact Details: 100-3480 Gilmore Way Burnaby British Columbia V5G 4W7 Canada Tel: 604 630-5061 Fax: 604.630-5103 Email: information@protivabio.com WWW: www.protivabio.com/

Loading...

Recent Publications by Protiva Biotherapeutics INC:
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. An analogous series of cationic lipids...	15th December, 2005	Protiva Biotherapeutics Inc., 100-3480 Gilmore Way, Burnaby, B.C., Canada	J Control Release. 2005 Oct 3;107(2):276-87. DOI Direct Link
A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA. PURPOSE: A fully scalable and extrusion-free method was developed to...	10th August, 2005	Protiva Biotherapeutics Inc., Burnaby, British Columbia, Canada V5G 4Y1.	Pharm Res. 2005 Mar;22(3):362-72.
Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression. Stabilized plasmid lipid particles (SPLP) consist of a single copy of DNA...	22nd July, 2005	Protiva Biotherapeutics Inc., 100-3480 Gilmore Way, Burnaby, BC, Canada	Biochim Biophys Acta. 2005 May 20;1669(2):155-63. Epub 2005 Feb 24. DOI Direct Link

BioNews Results for Protiva Biotherapeutics INC:
Pfizer Global Research Network	All American Patriots:  Nov 12 2009 1:40PM Matching: biotherapeutics inc
Pfizer announces global research network as part of integration of Pfizer and Wyeth	PharmaBiz:  Nov 11 2009 8:28AM Matching: biotherapeutics inc
Pfizer Announces Global Research Network	PharmiWeb:  Nov 11 2009 4:34AM Matching: biotherapeutics inc
Pfizer Reducing R&D Space After Wyeth Acquisition	CoStar Group:  Nov 11 2009 6:21PM Matching: biotherapeutics inc
News and FDA Updates for SuperGen (Nasdaq:SUPG), Talecris (Nasdaq:TLCR), Walgreens (NYSE:WAG)	Pharmacy Choice:  Nov 10 2009 11:51PM Matching: biotherapeutics inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Protiva Biotherapeutics INC news.

Protiva Biotherapeutics INC Patents:
US Patent No.	Title
6841537	Combination therapy using nucleic acids and conventional drugs
6410328	Sensitizing cells to compounds using lipid-mediated gene and compound delivery

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 467 times since April 2007, the link to the organisation's website has been followed 59 times

Recent Search Terms used to find this page: Protiva Biotherapeutics Inc | Protiva Biotherapeutics Inc burnaby | protiva biotherapeutics wa. | Protiva Biotherapeutics, Inc. wa fax | Protiva Biotherapeutics Inc headquarter | protiva | 100-3480 Gilmore Way | protiva patents | .

Search for more companies in Burnaby

Search for more companies in British Columbia

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Protiva Biotherapeutics INC